Live Breaking News & Updates on Data Monitoring Committees

Stay updated with breaking news from Data monitoring committees. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Remote care approach improved therapy adheren

<p>A new study by investigators from Mass General Brigham &nbsp;demonstrated that a remote team focused on identifying, educating and prescribing therapy can improve guideline-directed-medical-therapy (GDMT) adherence in patients with type 2 diabetes and high cardiovascular and/or kidney risk. The research team observed that patients who received education simultaneously with medication management demonstrated a higher rate of medication uptake and initiated treatment earlier compared to patients who received education over two months prior to medication management.</p>
....

United States , Benjaminm Scirica , Thomasa Gaziano , Caitlin Colling , Shahzad Hassan , Samuelj Aronson , Ryan Ruggiero , Carey Robar , Jacqueline Chasse , Jorge Plutzky , Daniel Gabovitch , Deborahj Wexler , Gemma Collins , Emily Zacherle , Lee Shing Chang , Christian Figueroa , David Zelle , Novo Nordisk , Novo Nordisk Foundation , Vascular Center At Brigham , Division Of Cardiovascular Medicine , American College Of Cardiology Annual Scientific Session , Novo Nordisk Inc , Method Of Research , Mass General Brigham , Annual Scientific Session ,

FDA Proposes Rule to Update Clinical Trial Data Monitoring | McDermott Will & Emery

On February 13, 2024, the US Food and Drug Administration (FDA) issued draft guidance entitled Use of Data Monitoring Committees in Clinical Trials (Draft Guidance). It provides. ....

Drug Administration , Mcdermott Will , Data Monitoring Committees , Clinical Trials , Draft Guidance , Clinical Trial Data Monitoring ,

FDA Issues Draft Guidance on Use of Data Monitoring Committees in Clinical Trials | King & Spalding

The U.S. Food and Drug Administration (FDA or Agency) has issued draft guidance, Use of Data Monitoring Committees in Clinical Trials, that applies to sponsors of clinical trials of. ....

King Spalding , Drug Administration , Data Monitoring Committees , Clinical Trials , Clinical Trial Data Monitoring Committees , Institutional Review Board , Draft Guidance , Clinical Trial Sponsors ,